Most interestingly, this CaM antagonist also inhibited EMT in vivo as evidenced by the decreased expression of the EMT markers N-cadherin and the transcription factors Snail and Slug, increasing on the other hand the level of E-cadherin in the tumor cells [80]. This evidence concerns the gene CALM2 and neoplasm.